8 assets in Bronchial Neoplasm

Therapeutic assets addressing Bronchial Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Bronchial Neoplasm	Nanfang Hospital, Southern Medical University	P3	BB (68)
Adebrelimab Bronchial Neoplasm	Nanfang Hospital, Southern Medical University	P2	CCC (53)
Cis-Diamminedichloroplatinum Ii Bronchial Neoplasm	Nanfang Hospital, Southern Medical University	P2	CCC (53)
Etoposide Bronchial Neoplasm	Nanfang Hospital, Southern Medical University	P2	CCC (53)
Nivolumab Bronchial Neoplasm	University of Colorado, Denver	P2	CCC (53)
Blu-701 Bronchial Neoplasm	Blueprint Medicines Corporation	P1	CC (43)
Osimertinib Bronchial Neoplasm	Blueprint Medicines Corporation	P1	CC (43)
Pebezertinib Bronchial Neoplasm	Blueprint Medicines Corporation	P1	CC (43)